e-learning
resources
Berlin 2008
Monday, 06.10.2008
Airway infection and host defence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia
E. Makarova, N. Menkov, N. Egorova, V. Njvjkov (Nizhniy Novgorod, Russian Federation)
Source:
Annual Congress 2008 - Airway infection and host defence
Session:
Airway infection and host defence
Session type:
Thematic Poster Session
Number:
1998
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Makarova, N. Menkov, N. Egorova, V. Njvjkov (Nizhniy Novgorod, Russian Federation). Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia. Eur Respir J 2008; 32: Suppl. 52, 1998
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Decrease of soluble adhesion molecules levels and bacterial mixt-infection in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Serum and r32kd induced cytokine levels and expression in tuberculosis patients and contacts
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
The content of soluble forms of activated molecules of leukocytes in the blood serum of patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004
Increased levels of soluble intercellular adhesion molecule 1 in active smokers
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired pneumonia
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Plasma concentrations of costimulatory molecules are altered in children with chronic stable asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 616s
Year: 2005
Total antioxidant capacity and C-reactive protein levels in patients with community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002
Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002
Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Smoking prevalence and its effect on lung function and soluble adhesion molecules levels in medical students
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 140s
Year: 2002
Measurement of procalcitonin levels in children with bacterial or viral acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 191s
Year: 2002
The effect of intravenous immunoglobulin on active oxygen forms production in patients with community acquired pneumonia
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
Serum eosinophilic cationic protein levels in toll collectors
Source: Annual Congress 2007 - Experimental and observational studies with environmental agents
Year: 2007
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Serum kinetics of total leptin and soluble leptin receptor as prognostic tools in sepsis.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept